BRCA Mutation Association with Recurrence Score and Discordance in a Large Oncotype Database
Author:
Publisher
S. Karger AG
Subject
Cancer Research,Oncology,General Medicine
Reference11 articles.
1. McAndrew NP, Maxwell KN, Stopfer J, Powers J, Brandt AC, Long JM, et al. Oncotype DX scores in BRCA1 and BRCA2 associated breast cancer. J Clin Oncol. 2015;33(15_Suppl l):541.
2. Halpern N, Sonnenblick A, Uziely B, Divinsky L, Goldberg Y, Hamburger T, et al. Oncotype Dx recurrence score among BRCA1/2 germline mutation carriers with hormone receptors positive breast cancer. Int J Cancer. 2017;140(9):2145–9. .
3. Shah PD, Patil S, Dickler MN, Offit K, Hudis CA, Robson ME. Twenty-one-gene recurrence score assay in BRCA-associated versus sporadic breast cancers: differences based on germline mutation status. Cancer. 2016;122(8):1178–84.
4. Lewin R, Sulkes A, Shochat T, Tsoref D, Rizel S, Liebermann N, et al. Oncotype-DX recurrence score distribution in breast cancer patients with BRCA1/2 mutations. Breast Cancer Res Treat. 2016;157(3):511–6.
5. Sparano JA, Gray RJ, Ravdin PM, Makower DF, Pritchard KI, Albain KS, et al. Clinical and genomic risk to guide the use of adjuvant therapy for breast cancer. N Engl J Med. 2019;380(25):2395–405.
Cited by 6 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. BRCA1/2 mutation carriers vs the general breast cancer population (N = 799,986): 21-gene assay-based molecular characterization;Breast Cancer Research and Treatment;2024-04-03
2. Prognostic and Predictive Biomarkers in Familial Breast Cancer;Cancers;2023-02-20
3. Genetic and clinical characteristics of BRCA-associated hereditary breast cancer in the West region of Kazakhstan;Carcinogenesis;2022-08-02
4. Stress, anxiety, and health-related quality of life in BRCA1/2-positive women with and without cancer: A comparison of four US female samples;Gynecologic Oncology Reports;2022-08
5. Clinical outcomes and Oncotype DX Breast Recurrence Score® in early‐stage BRCA ‐associated hormone receptor‐positive breast cancer;Cancer Medicine;2022-02-06
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3